Healthcare & Pharmaceuticals Blog
As Seen In
In an interview with The Lawyer, WSG member Simon McArdle, Partner at Shoosmiths, shares his advice to GCs for initial approach to implementation of legal tech solutions. McArdle gives his advice on how to ensure the best strategic implementation...
Services
Region
Industries
- Agriculture
- Corporate & Business
- Crossborder Trade & Investment
- Dispute Resolution
- Employment & Labor
- Energy & Natural Resources
- Environmental
- Financial Services
- Government & Public Sector
- Healthcare & Pharmaceuticals
- Hospitality, Media & Leisure
- Industrial & Manufacturing
- Insurance
- Life Sciences
- Real Estate & Construction
- Retail & Distribution
- Taxation
- Technology
- Telecommunications
- Transportation
Recent Posts
- Blog: ALTIUS BlogsThe Act of 2002 on combating late payment in commercial transactions undergoes further modifications to fight companies’ liquidity problemsPosted on October 21, 2021 by On 15 July 2021, the Act of 2 August 2002 on combating late payment in commercial transactions was modified to address companies’ liquidity problems due to the late payment behaviour of their business customers. The new Act brings about two changes: first, the payment term agreed between the parties in all commercial transactions will have to be limited to a maximum of 60 days, irrespective of the parties’ companies’ sizes; second, the acceptance or verification procedure for the conformity of goods or services must in the future be included in the maximum payment term of 60 days. Introdu...
- Blog: Waller Law BlogRepresentation and Warranty Insurance (RWI) in healthcare provider deals: what you need to know for year-end 2021Posted on October 20, 2021 by Dealmakers with a mandate to close by year-end should plan ahead and fast-track due diligence processes.
- Blog: Homeostasis: Dykema Health Care Law BlogImportant Enforcement Updates on No Surprises Act and Transparency RequirementsPosted on September 13, 2021 by Kathleen A. Reed, David R. PadalinoHealth plans and insurers will have a little more time to comply with some of the multitude of new requirements under the Consolidated Appropriations Act (“CAA”). On August 20, 2021, the Departments of Labor, Health and Human Services, and the Treasury (the “Departments”) issued an FAQ updating plans and issuers on critical enforcement guidance for several CAA transparency measures. The Departments have acknowledged that plans and issuers are struggling to comply with the litany, and complexity, of transparency requirements the CAA imposes, going so far as to note that...
- Blog: Patent 213Another Gaming Patent Struck Down as IneligiblePosted on July 19, 2021 by Stephanie D. ScruggsBot M8 LLC, a patent assertion entity, was unsuccessful in its effort to have the Federal Circuit reverse the lower court’s invalidity finding related to one of six different patents asserted against Sony in Northern District of California. In fact, the Federal Circuit was so unpersuaded by Bot M8’s arguments that it devoted less than...
- Blog: Biologics BlogFederal Circuit Upholds Jury Award, Weighs in on Willfulness Standard, in Adynovate® DisputePosted on March 29, 2021 by According to the Federal Circuit, $173 million was the right damages award for almost three years of patent infringement resulting from Baxalta’s sale of its biologic product Adynovate® (Antihemophilic Factor (Recombinant), PEGylated). In Bayer Healthcare LLC v. Baxalta Inc., et al., Nos. 2019-2418, 2020-1017 (Fed. Cir. 2021), the circuit court upheld an award to Bayer [...]
- Blog: Chemical Law & Prop 65 BlogMajor Changes Coming to Prop 65 “Short-Form” WarningsPosted on February 1, 2021 by By: Anne Marie Ellis, John Epperson, Peter McGaw
